SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 26.36 |
Enterprise Value ($M) | 118.54 |
Book Value ($M) | -97.44 |
Book Value / Share | -10.53 |
Price / Book | -0.27 |
NCAV ($M) | -113.70 |
NCAV / Share | -12.29 |
Price / NCAV | -0.23 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -3.48 |
Return on Assets (ROA) | -1.08 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.69 |
Current Ratio | 1.69 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 46.36 |
Assets | 62.61 |
Liabilities | 160.06 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Athyrium Opportunities 2020 LP | 32.70 | 28.96 | |
13G | Armistice Capital, Llc | 5.70 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
34,172 | 121,560 | 28.11 | |
28,573 | 61,859 | 46.19 | |
17,782 | 71,137 | 25.00 | |
21,101 | 79,269 | 26.62 | |
(click for more detail) |
Similar Companies | |
---|---|
BHSE – Bull Horn Holdings Corp. | BHSEU – Bull Horn Holdings Corp. Unit |
BIIB – Biogen Inc | BIVI – BioVie Inc |
BLCM – Bellicum Pharmaceuticals Inc |
Financial data and stock pages provided by
Fintel.io